Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Dual Testing Recommended for Diabetic Children

By LabMedica International staff writers
Posted on 17 May 2011
The hemoglobin A1C (HbA1C) blood test should be used in conjunction with the oral glucose tolerance test for screening overweight children for diabetes. More...


Although the glycosalated HbA1C blood test is easier on the patient, as it does not require fasting, it may not be sensitive to catch overweight children who are at a high risk of developing type 2 diabetes.

Scientists at the Children's Mercy Hospital (Kansas City, MO, USA) evaluated the charts of 629 overweight and adolescent patients who had both the HbA1c and an oral glucose test. They found that 40% of type 2 diabetes patients and 67% of high-risk patients identified through the oral glucose tolerance test would have shown a normal glycemic status if only the hemoglobin A1C test were used to diagnose them. Nearly nine out of ten patients had normal blood glucose levels according to their hemoglobin A1C results.

The study found that the recommended blood test may not be enough to detect type 2 diabetes in overweight children, missing more than two-thirds of children at high-risk for the condition. The investigators found that performing two tests, both the recommended hemoglobin A1C test and an oral glucose tolerance test, could dramatically reduce the risk of delayed diagnosis in overweight children.

Wayne Moore, MD, PhD, chief and medical director of the endocrine/diabetes section at Children's Mercy Hospital, said, "Lifestyle changes and early treatment can help delay disease progression of diabetes. It is important that patients are diagnosed as early as possible for the best outcomes." The findings were presented at the Pediatric Academic Societies Annual Meeting, held from April 30 – May 3, 2011, in Denver (CO, USA).

Related Links:
Children's Mercy Hospital





New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.